Alpha-9 Oncology
BiotechnologyWebsite
Alpha-9 Oncology valuation and funding history | Last updated: October 23, 2024 | 1 funding rounds
Current Valuation
N/A
As of October 23, 2024
Total Funding Raised
$261.1M
Across 1 round
Last Round
Later Stage VC
$175.0M
Last Funding
Oct 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 23, 2024 | Later Stage VC (Series C) | $175.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Alpha-9 Oncology is currently valued at N/A as of October 23, 2024. The company has raised a total of $261.1M in funding across 1 funding round.
What is Alpha-9 Oncology Worth in 2026?
Alpha-9 Oncology is a leading private company in the Biotechnology sector. Track Alpha-9 Oncology's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Alpha-9 Oncology Valuation is Determined
Private company valuations like Alpha-9 Oncology's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.